These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29800181)

  • 1. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
    Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
    JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.
    Wille-Jørgensen P; Syk I; Smedh K; Laurberg S; Nielsen DT; Petersen SH; Renehan AG; Horváth-Puhó E; Påhlman L; Sørensen HT;
    JAMA; 2018 May; 319(20):2095-2103. PubMed ID: 29800179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
    Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
    Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
    Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
    JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial.
    Egenvall M; Martling A; Veres K; Horváth-Puhó E; Wille-Jørgensen P; Høirup Petersen S; Laurberg S; Sørensen HT; Syk I;
    Eur J Surg Oncol; 2021 Aug; 47(8):2053-2059. PubMed ID: 33846037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical follow-up does not improve survival after resection of stage I-III colorectal cancer: A cohort study.
    Jones RP; McWhirter D; Fretwell VL; McAvoy A; Hardman JG
    Int J Surg; 2015 May; 17():67-71. PubMed ID: 25827817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
    Khan K; Athauda A; Aitken K; Cunningham D; Watkins D; Starling N; Cook GJ; Kalaitzaki E; Chau I; Rao S
    Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection.
    Su BB; Shi H; Wan J
    World J Gastroenterol; 2012 May; 18(17):2121-6. PubMed ID: 22563201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer.
    Fakih M; Sandhu J; Wang C; Kim J; Chen YJ; Lai L; Melstrom K; Kaiser A
    JAMA Netw Open; 2022 Mar; 5(3):e221093. PubMed ID: 35258578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
    Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
    Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
    Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
    Spratlin JL; Hui D; Hanson J; Butts C; Au HJ
    Clin Colorectal Cancer; 2008 Mar; 7(2):118-25. PubMed ID: 18501071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers.
    Søreide K; Søreide JA; Kørner H
    World J Surg; 2011 Apr; 35(4):888-94. PubMed ID: 21301835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up : FDG PET in recurrent colorectal CA.
    Özkan ZG; Has Şimşek D; Kuyumcu S; Oflas M; Işık EG; Doğan İ; Karabulut S; Şanlı Y
    Ann Nucl Med; 2022 Jan; 36(1):52-60. PubMed ID: 34648169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.
    Rodríguez-Moranta F; Saló J; Arcusa A; Boadas J; Piñol V; Bessa X; Batiste-Alentorn E; Lacy AM; Delgado S; Maurel J; Piqué JM; Castells A
    J Clin Oncol; 2006 Jan; 24(3):386-93. PubMed ID: 16365182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor surveillance after resection of colorectal cancer].
    Vorburger SA; Gloor B; Candinas D
    Ther Umsch; 2008 Jun; 65(6):329-34. PubMed ID: 18622956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
    Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
    Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
    Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY
    BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.